GLP-1已成为让所有竞争者都有危机感的赛道文 | 凌馨编 | 王小图/视觉中国盼着“减肥神药”再次推动医药股大涨的股民们,可能失望了。全球最大的糖尿病学术年会于当地时间2025年6月20日—23日在美国芝加哥举行。围绕这次会议,中国从事GLP-1药物开发的一批公司如恒瑞医药、华东医药、甘李药业、信达生物等,都铆足了劲宣传。但,哪家的股价都没咋涨。会前,中国投资者曾对2025年美国糖尿病协会科学...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.